Obituary: Rudolf Kunze
22.05.2023
On monday, May 22nd 2023 our great friend mentor and provider of ideas Dr. Rudolf Kunze passed away, peacefully. He leaves a great void. We miss him.
Update on the clinical relevance of the C-reactive protein in Forum Sanitas
25.04.2023
An update on the clinical relevance of the C-reactive protein was published in the second edition of 2023 in the medical magazine Forum Sanitas. Dr. Wolfgang Ries and Dr. Fabrizio Esposito report from the practice of therapies for acute, necrotic pancreatitis and severe myocardial infarction.
Positive assessment of the potential of CRP apheresis by the G-BA
16.05.2023
Zum Klären der Effizienz der CRP-Apherese-Therapie hat sich die Pentracor GmbH bereits im November 2022 an den G-BA (Gemeinsamer Bundesausschuss, das oberste Beschlussgremium der gemeinsamen Selbstverwaltung im deutschen Gesundheitswesen) gewendet.
Pentracor at the annual convention of the German Cardiac Society
19.04.2023
We have been at the 89th annual convention of the German Cardiac Society in Mannheim where we had great conversations with new and old contacts in the cardiologists community.
New comment on CRP apheresis
22.03.2023
An article entitled “C-reactive Protein Apheresis in Acute Myocardial Infarction” was published in the journal Current Pharmaceutical Design, April 2023 issue, and addresses the topic of C-reactive protein apheresis (CRP-A) therapy in patients with acute myocardial infarction.
FDA grants designation as Breakthrough Device
28.11.2022
The FDA has granted PentraSorb CRP designation as a Breakthrough Device. A remarkable achievement.
Feature Paper in Journal of Clinical Medicine
31.10.2022
A further analyses of out CAMI-1 study hast been published as a feature paper in the Journal of Clinical Medicine.
